New hope for painful skin condition: drug trial launches

NCT ID NCT07492251

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a daily pill called upadacitinib for people with severe forms of lichen planus, a skin disease causing painful mouth sores or hair loss. About 56 adults will receive either the drug or a placebo for 16 weeks to see if it reduces symptoms. The goal is to control the disease, not cure it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LICHEN PENIS PLANUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

balanitis xerotica obliterans lichen planopilaris lichen planus oral erosive lichen

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • APHP

    Paris, France

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

    Contact

  • CHU de Nice

    Nice, Alpes Maritimes, 06200, France

    Contact Email: •••••@•••••

    Contact

  • CHU de Rouen

    Rouen, France

    Contact Email: •••••@•••••

    Contact

  • CHU de Tours

    Tours, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Centre privé de Dermatologie

    Reims, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact